PRF Technologies Ltd. — Form SCHEDULE 13D/A
Filed November 3, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
S.H.N. Financial Investments Ltd. filed an amended Schedule 13D for PRF Technologies Ltd. (a $12M-asset Israeli pharmaceutical company) on November 3, 2026. The filing does not specify the amended ownership percentage, share count, or dollar amount of the stake — only that an amendment was made to a prior beneficial ownership disclosure. Without the specific details of what changed in the amendment, the material impact cannot be quantified.
Why this rating
Amendment to ownership disclosure suggests a change in stake, but lacks specifics (%, shares, $) needed to assess materiality. Routine compliance filing without concrete new information.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.